“…In relation to gender, this study found higher prevalence among women, with significant association and PR = 2.44 (95%CI 1.68 -3.56). In previous studies conducted with inpatients, there were similar prevalence results 7,3,10 . The prevalence of women amongst patients with depressive or anxiety disorders was confirmed by specialized scientific literature 18,19 .…”
Section: Discussionsupporting
confidence: 79%
“…The high prevalence (around 65%) was related to patients in preoperative or those with chronic pain 8,9 . Other situations, like the fact of being unemployed, are related to higher levels of anxiety during hospitalization 8 . The female gender proved to be associated with higher levels of anxiety during hospitalization in relation to the opposite gender 10 .…”
This study found prevalence of high anxiety. It may be associated with certain characteristics of the patients (gender, age, chronic diseases); the medical appointment in primary care and time (estimated by the patient) that the student remained with this patient. The need for a focused approach to mental health care within the hospital has been discussed for a long time. The particularity of this study refers to the environment of a university hospital and to what extent the environment and the patient's relationship with the student are associated with higher prevalence of anxiety.
“…In relation to gender, this study found higher prevalence among women, with significant association and PR = 2.44 (95%CI 1.68 -3.56). In previous studies conducted with inpatients, there were similar prevalence results 7,3,10 . The prevalence of women amongst patients with depressive or anxiety disorders was confirmed by specialized scientific literature 18,19 .…”
Section: Discussionsupporting
confidence: 79%
“…The high prevalence (around 65%) was related to patients in preoperative or those with chronic pain 8,9 . Other situations, like the fact of being unemployed, are related to higher levels of anxiety during hospitalization 8 . The female gender proved to be associated with higher levels of anxiety during hospitalization in relation to the opposite gender 10 .…”
This study found prevalence of high anxiety. It may be associated with certain characteristics of the patients (gender, age, chronic diseases); the medical appointment in primary care and time (estimated by the patient) that the student remained with this patient. The need for a focused approach to mental health care within the hospital has been discussed for a long time. The particularity of this study refers to the environment of a university hospital and to what extent the environment and the patient's relationship with the student are associated with higher prevalence of anxiety.
“…La prevalencia de depresión y ansiedad en hospitales generales es muy alta [2][3][4] , esto constituye un problema que afecta la salud de los usuarios y su pronóstico vital. La depresión se ha asociado a una estancia hospitalaria más prolongada, mayores costos y mayor número de procedimientos 2 .…”
The prevalence of depression and anxiety in pacients hospitalized in general hospitals is very high, this is associated with increased morbidity and mortality and higher health costs. Emotional support is essential in any recovery process. Method: A descriptive and analytical study was carried out on depression and its relationship with social support, hospital stay and medical illness in patients admitted to the Dr. Manuel Quintela Clinical Hospital Montevideo-Uruguay. The Beck test for depression and the scale validated for social support Medical Outcomes Study (MOS) were applied. Characteristics of the studied population were described. Results: More than half of the interviewees presented some degree of depesión. It was possible to affirm that 73.7% of the users with scarce social support presented depressive symptoms with an increase in depression, especially of moderate and mild type. There was a higher incidence of depression in patients with prolonged hospital stay, however this data was not statistically significant. Regarding medical pathology, we highlight the strong presence of depression in cardiovascular and surgical oncology patients.
“…Suele ser temporal y percibida como intranquilidad y angustia; en algunas ocasiones hasta como terror y pánico (Hernández, Orellana, Kimelman, Nuñez, & Ibáñez, 2005). Es así que, dependiendo de la intensidad y repercusión sobre la actividad de la persona puede tratarse de una emoción normal o de un trastorno psiquiátrico (Hurlé, 2003).…”
Section: Introductionunclassified
“…Por otro lado, si la reacción se vuelve constante, intensa, automática y desproporcionada frente a la situación que la desencadena, y a la vez propicia conductas de evitación o retraimiento, el cuadro ansioso podría ser considerado como trastornos mentales, tales como episodios depresivos, maníacos, psicóticos, etc. (Hernández et al, 2005).…”
ResumenLa ansiedad es uno de los problemas psicológicos que más afecta a la sociedad, encontrándose que cada vez más individuos la padecen. Según información estadística de la Organización Mundial de Salud -OMS (2016) el 20% de la población mundial posee predisposición para presentar algún tipo de cuadro ansioso en algún momento de su vida. Perú, no es ajeno a esta realidad, siendo las benzodiazepinas (BZD), los fármacos utilizados de forma generalizada en la práctica clínica para tratar estos problemas de ansiedad. Por consiguiente, el presente estudio plantea como objetivo describir el mecanismo de acción del mencionado fármaco, así como la farmacocinética del medicamento, sus aplicaciones terapéuticas y efectos adversos; además, cómo difundir información actualizada acerca de sus propiedades.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.